Defined Bioscience
PrivateLast Round
Seed
Apr 4, 2025
Total Funding Raised
$2.77M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Defined Bioscience operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in October 2023.
Defined Bioscience is a biotechnology company that develops high-performance, animal-free media and reagents tailored for stem cell research, organoid development, and cultured meat production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Defined Bioscience Comparables
Compare Defined Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BIOM Innovations | 81% | |
| NouBio | 79% | |
| KCell Biosciences | 76% |
For institutional investors. Book with your work email.
Defined Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 4, 2025 | ||||
| Grant | Oct 27, 2023 | ||||
| Grant | Jun 23, 2021 | ||||
| Grant | May 17, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Defined Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of General Medical Sciences | Grant |
| California Institute for Regenerative Medicine | Grant |
| Phase Two Ventures | Pre Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Grew 40% QoQ, from 10 to 14 employees.
- Jul 27, 2026
Monthly visitors grew 100% MoM, reaching 4.3K.
For institutional investors. Book with your work email.
Defined Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Defined Bioscience's valuation, stock price, and market status.
Is Defined Bioscience a public or private company?
Defined Bioscience is a private company.
What is the current stock price of Defined Bioscience?
Defined Bioscience is a private company, so its shares have no public market price. Caplight tracks Defined Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Defined Bioscience worth (valuation)?
Valuation information for Defined Bioscience is not publicly available.
Can I buy Defined Bioscience stock?
Defined Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Defined Bioscience's last funding round?
Defined Bioscience's most recent funding round was Seed on April 4, 2025.
Who are the main investors in Defined Bioscience?
Key investors in Defined Bioscience include National Institute of General Medical Sciences, California Institute for Regenerative Medicine, Phase Two Ventures, National Science Foundation.
Will Defined Bioscience IPO soon?
No public IPO plans have been announced for Defined Bioscience.
How can I track Defined Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Defined Bioscience's shares on secondary markets.